Advances in Urologic Imaging Prostate-Specific Membrane Antigen Ligand PET Imaging

被引：31

作者：

Hofman, Michael S. ^{[1
,2
]}

Iravani, Amir ^{[1
]}

Nzenza, Tatenda ^{[3
,4
]}

Murphy, Declan G. ^{[3
]}

机构：

[1] Peter MacCallum Canc Ctr, Ctr Mol Imaging, Dept Canc Imaging, 305 Grattan St, Melbourne, Vic 3000, Australia

[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, 305 Grattan St, Melbourne, Vic 3000, Australia

[3] Univ Melbourne, Sir Peter MacCallum Dept Surg Oncol, 305 Grattan St, Melbourne, Vic 3000, Australia

[4] Austin Hosp, 305 Grattan St, Melbourne, Vic 3000, Australia

来源：

UROLOGIC CLINICS OF NORTH AMERICA | 2018年 / 45卷 / 03期

关键词：

Prostate cancer; Prostate-specific membrane antigen; PET; PSMA PET/CT; PSMA PET; EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY; SMALL-MOLECULE INHIBITORS; MONOCLONAL-ANTIBODY J591; ESTRO-SIOG GUIDELINES; LYMPH-NODE DISSECTION; PART II TREATMENT; RADIATION-DOSIMETRY; MAGNETIC-RESONANCE; GA-68-PSMA PET/CT; BIOCHEMICAL RECURRENCE;

D O I：

10.1016/j.ucl.2018.03.016

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Radiolabeled prostate-specific membrane antigen (PSMA) PET is emerging as an important modality for imaging prostate cancer (PCa). Promising clinical experience has led to increasing number of studies exploring the role of PSMA PET in different aspects of PCa, including primary detection, risk stratification, targeted biopsy, initial staging, restaging at biochemical recurrence, biologic characterization, treatment response assessment, and prognostication. PSMA PET may prove an important disease biomarker, expand our understanding of the pathogenesis, and pave the way for personalized management of PCa.

引用

页码：503 / +

页数：23

共 128 条

[51]

Giesel F, 2017, J NUCL MED

[52] Intra-individual comparison of 68Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer [J].

Giesel, F. L. ;

Sterzing, F. ;

Schlemmer, H. P. ;

Holland-Letz, T. ;

Mier, W. ;

Rius, M. ;

Afshar-Oromieh, A. ;

Kopka, K. ;

Debus, J. ;

Haberkorn, U. ;

Kratochwil, C. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (08) :1400-1406

[53] F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients [J].

Giesel, Frederik L. ;

Hadaschik, B. ;

Cardinale, J. ;

Radtke, J. ;

Vinsensia, M. ;

Lehnert, W. ;

Kesch, C. ;

Tolstov, Y. ;

Singer, S. ;

Grabe, N. ;

Duensing, S. ;

Schaefer, M. ;

Neels, O. C. ;

Mier, W. ;

Haberkorn, U. ;

Kopka, K. ;

Kratochwil, C. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (04) :678-688

[54] 11C-Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen-Deprivation Therapy [J].

Giovacchini, Giampiero ;

Picchio, Maria ;

Garcia-Parra, Rita ;

Briganti, Alberto ;

Abdollah, Firas ;

Gianolli, Luigi ;

Schindler, Christian ;

Montorsi, Francesco ;

Messa, Cristina ;

Fazio, Ferruccio .

JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (02) :233-241

[55] PET/CT With 68Ga-DOTA-TATE for Diagnosis of Neuroendocrine Differentiation in Patients With Castrate-Resistant Prostate Cancer [J].

Gofrit, Ofer Nathan ;

Frank, Stephen ;

Meirovitz, Amichay ;

Nechushtan, Hovav ;

Orevi, Marina .

CLINICAL NUCLEAR MEDICINE, 2017, 42 (01) :1-6

[56] Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study [J].

Gorin, Michael A. ;

Rowe, Steven P. ;

Patel, Hiten D. ;

Vidal, Igor ;

Mana-ay, Margarita ;

Javadi, Mehrbod S. ;

Solnes, Lilja B. ;

Ross, Ashley E. ;

Schaeffer, Edward M. ;

Bivalacqua, Trinity J. ;

Partin, Alan W. ;

Pienta, Kenneth J. ;

Szabo, Zsolt ;

De Marzo, Angelo M. ;

Pomper, Martin G. ;

Allaf, Mohamad E. .

JOURNAL OF UROLOGY, 2018, 199 (01) :126-132

[57] Radiofluorinated Derivatives of 2-(Phosphonomethyl)pentanedioic Acid as Inhibitors of Prostate Specific Membrane Antigen (PSMA) for the Imaging of Prostate Cancer [J].

Graham, Keith ;

Lesche, Ralf ;

Gromov, Alexey V. ;

Boehnke, Niels ;

Schaefer, Martina ;

Hassfeld, Jorma ;

Dinkelborg, Ludger ;

Kettschau, Georg .

JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) :9510-9520

[58] 68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy - diagnostic performance and impact on therapeutic decision-making [J].

Grubmueller, B. ;

Baltzer, P. ;

D'Andrea, D. ;

Korn, S. ;

Haug, A. R. ;

Hacker, M. ;

Grubmueller, K. H. ;

Goldner, G. M. ;

Wadsak, W. ;

Pfaff, S. ;

Babich, J. ;

Seitz, C. ;

Fajkovic, H. ;

Susani, M. ;

Mazal, P. ;

Kramer, G. ;

Shariat, S. F. ;

Hartenbach, Markus .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (02) :235-242

[59] EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer [J].

Heidenreich, Axel ;

Bastian, Patrick J. ;

Bellmunt, Joaquim ;

Bolla, Michel ;

Joniau, Steven ;

van der Kwast, Theodor ;

Mason, Malcolm ;

Matveev, Vsevolod ;

Wiegel, Thomas ;

Zattoni, Filiberto ;

Mottet, Nicolas .

EUROPEAN UROLOGY, 2014, 65 (02) :467-479

[60] Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients [J].

Herlemann, Annika ;

Kretschmer, Alexander ;

Buchner, Alexander ;

Karl, Alexander ;

Tritschler, Stefan ;

El-Malazi, Lina ;

Fendler, Wolfgang P. ;

Wenter, Vera ;

Ilhan, Harun ;

Bartenstein, Peter ;

Stief, Christian G. ;

Gratzke, Christian .

ONCOTARGET, 2017, 8 (48) :84180-84192

← 1 2 3 4 5 6 7 8 9 10 →